GenMark Diagnostics to Report Third Quarter 2020 Financial Results on October 28, 2020
October 14, 2020 17:20 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close...
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) Receives EUA from FDA
October 08, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
RP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2 Panel) has received Emergency Use Authorization from the FDA.The RP2 Panel provides results in less than two hours for more...
GenMark Diagnostics Provides Preliminary Financial Results for Third Quarter 2020
October 08, 2020 16:03 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
Le Panel de pathogènes respiratoires 2 (RP2) ePlex de GenMark Diagnostics obtient le marquage CE
September 15, 2020 09:04 ET
|
GenMark Diagnostics, Inc.
Le test syndromique moléculaire pour la COVID-19, la grippe et d'autres pathogènes respiratoires courants aide les professionnels de santé à se préparer à la saison de la grippe Le Panel RP2 en un...
GenMark Diagnostics’ ePlex® Respiratory Pathogen Panel 2 (RP2) achieves CE Mark
September 14, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
Molecular syndromic test for COVID-19, influenza and other common respiratory pathogenshelps health care professionals prepare for flu season RP2 Panel at a Glance GenMark’s ePlex® Respiratory...
GenMark Diagnostics Announces Submission of Emergency Use Authorization for its eSensor® SARS-CoV-2 Test
August 17, 2020 08:00 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that it has...
GenMark Diagnostics Reports Second Quarter 2020 Results
August 04, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
July 29, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020
July 21, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close...
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
July 07, 2020 16:05 ET
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...